RECRUITING

Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Cervical cancer is a disease that is preventable through vaccination against the virus that causes it, human papillomavirus (HPV), and through screening and treatment of cervical disease before it becomes cancet.

Official Title

Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening

Quick Facts

Study Start:2023-10-30
Study Completion:2030-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06109870

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Provision of signed and dated informed consent form
  2. * Currently resident in RGV
  3. * Stated willingness to comply with all study procedures
  4. * Females; Age ≥30 years
  5. * Have no history of hysterectomy with removal of the cervix
  6. * Have no history of cervical cancer or high-grade dysplasia
  7. * have not had a Pap test in the past 3.5 years or Pap/HPV co-test in the past 5.5 years.
  1. * Unable to communicate in English or Spanish
  2. * Lack valid telephone contact information
  3. * Report being currently pregnant. 4.3 Vulnerable Populations

Contacts and Locations

Study Contact

Jane Montealegre, M D
CONTACT
(281) 814-7118
jrmontealegre@mdanderson.org

Principal Investigator

Jane Montealegre, M D
PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center

Study Locations (Sites)

University of Texas at Austin
Austin, Texas, 78712
United States
M D Anderson Cancer Center
Houston, Texas, 77030
United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

  • Jane Montealegre, M D, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-30
Study Completion Date2030-08-31

Study Record Updates

Study Start Date2023-10-30
Study Completion Date2030-08-31

Terms related to this study

Additional Relevant MeSH Terms

  • HPV